230 related articles for article (PubMed ID: 1985791)
1. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
2. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
[TBL] [Abstract][Full Text] [Related]
3. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
4. Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.
Möller P; Mattfeldt T; Gross C; Schlosshauer P; Koch A; Koretz K; Moldenhauer G; Kaufmann M; Otto HF
Am J Pathol; 1989 Jul; 135(1):73-83. PubMed ID: 2549795
[TBL] [Abstract][Full Text] [Related]
5. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
6. The role of surface HLA-A,B,C molecules in tumour immunity.
Möller P; Hämmerling GJ
Cancer Surv; 1992; 13():101-27. PubMed ID: 1423320
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
Chaux P; Moutet M; Faivre J; Martin F; Martin M
Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
[TBL] [Abstract][Full Text] [Related]
8. HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant.
Benevolo M; Mottolese M; Piperno G; Sperduti I; Cione A; Sibilio L; Martayan A; Donnorso RP; Cosimelli M; Giacomini P
Am J Surg Pathol; 2007 Jan; 31(1):76-84. PubMed ID: 17197922
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma.
Krishnakumar S; Sundaram A; Abhyankar D; Krishnamurthy V; Shanmugam MP; Gopal L; Sharma T; Biswas J
Cancer; 2004 Mar; 100(5):1059-69. PubMed ID: 14983503
[TBL] [Abstract][Full Text] [Related]
10. Histocompatibility profile of selected Latin American countries.
Santiago-Delpín EA
Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
[No Abstract] [Full Text] [Related]
11. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma.
Momburg F; Ziegler A; Harpprecht J; Möller P; Moldenhauer G; Hämmerling GJ
J Immunol; 1989 Jan; 142(1):352-8. PubMed ID: 2462591
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.
Oldford SA; Robb JD; Codner D; Gadag V; Watson PH; Drover S
Int Immunol; 2006 Nov; 18(11):1591-602. PubMed ID: 16987935
[TBL] [Abstract][Full Text] [Related]
13. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
15. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
Wilson KM; Labeta MO; Pawelec G; Fernandez N
Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
[TBL] [Abstract][Full Text] [Related]
17. Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy.
Ransom JH; Pelle B; Hanna MG
Cancer Res; 1992 Jun; 52(12):3460-6. PubMed ID: 1596903
[TBL] [Abstract][Full Text] [Related]
18. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
[TBL] [Abstract][Full Text] [Related]
20. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
Momburg F; Möller P
Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]